Objective: α 2 -macroglobulin (α 2 M) is an acute phase protein released to the serum upon challenges such as cardiac hypertrophy and infarction. Here we report on the role of α 2 M in the induction of hypertrophic cell growth, contractile responsiveness of rat ventricular cardiomyocytes, and on the underlying extracellular regulated kinase 1,2 (ERK1,2) and phosphoinositide 3-kinase (PI3-kinase)/Akt pathways. Methods: Cell volume and cross-sectional areas were assessed as parameters of hypertrophic growth, and real time RT-PCR for the analysis of hypertrophy-related genes was performed. Protein synthesis was analyzed by 14 C-phenylalanine incorporation. Activation of ERK1,2, PI3-kinase and Akt was assessed by immunohistochemical analysis of phosphorylated proteins. Contractile responsiveness was investigated by determination of cell shortening following electrical field stimulation. Intracellular calcium concentration [Ca 2+ ] i was determined by fluo-3 microfluorometry. Results: Treatment of ventricular cardiomyocytes for 24 h with α 2 M significantly increased cell volume and protein synthesis as well as expression of hypertrophy-associated genes [brain natriuretic protein (BNP), β-myosin heavy chain (β-MHC), myosin light chain-2 (MLC-2), atrial natriuretic factor (ANF), and skeletal α-actin]. Comparable effects were achieved by treatment of cells with an antibody directed against the α 2 M-receptor LDL receptor-related protein-1 (LRP-1) and counteracted upon coincubation with receptor-associated protein (RAP), suggesting an involvement of α 2 M-LRP-1 signalling. Furthermore, α 2 M treatment increased sarcoplasmic reticulum Ca 2+ -ATPase (SERCA2a) expression, diastolic and systolic [Ca 2+ ] i , and contractile responsiveness after electrical stimulation. Shortly after α 2 M stimulation, activation of ERK1,2, Akt, and PI3-kinase pathways was observed. Consequently, α 2 M-induced protein synthesis was inhibited upon treatment with the ERK1,2 inhibitor UO126 as well as by LY294002 and wortmannin, which inhibit PI3-kinase, and by rapamycin, which inhibits mammalian target of rapamycin (mTOR) downstream of Akt. Conclusions: Our data show that α 2 M induces hypertrophic cell growth in rat ventricular cardiomyocytes via ERK1,2 and PI3-kinase/Akt and improves cardiac cell function.